LAUSR

Market access of Spinraza (Nusinersen) for spinal muscular atrophy: intellectual property rights, pricing, value and coverage considerations

Sign Up to like & get
recommendations!
0 Published in 2017 at "Gene Therapy"

DOI: 10.1038/gt.2017.79

Abstract: Market access of Spinraza (Nusinersen) for spinal muscular atrophy: intellectual property rights, pricing, value and coverage considerations read more here.

Keywords: access spinraza; spinraza nusinersen; spinal muscular; muscular atrophy ... See more keywords